This randomized controlled trial aims to assess the effectiveness of Microcurrent Therapy and Transcutaneous Electrical Nerve Stimulation  in managing Primary Dysmenorrhea in young women. Primary dysmenorrhea refers to menstrual pain without underlying pelvic pathology and is a common gynecological complaint that impacts the quality of life, daily functioning, and psychological well-being.

Participants will be randomly allocated into two groups: Group A will receive Microcurrent therapy and group B will receive trancutaneuos electrical nerve stimulation therapy

Both interventions will be administered during the first three days of menstruation for three consecutive menstrual cycles. Each session will follow standardized parameters and treatment duration under the supervision of a trained physiotherapist. These therapies are safe, non-invasive, drug-free, and simple to administer, with minimal to no side effects, making them suitable for routine clinical use.

The study population will be recruited based on the selection criteria.

The following outcome measures will be assessed- cortisol, menstrual symptoms questionnaire, quality of life. Basic menstrual and Gynecological physiotherapy assessment will be carried out before intervention. Outcome assessments will be conducted at baseline and after completion of three treatment cycles to evaluate the treatment effects.

All participants will receive a participant information sheet that clearly outlines the study’s purpose, procedures, potential benefits, and risks. Written informed consent will be obtained prior to participation, ensuring full understanding, confidentiality and voluntary involvement. Participants may withdraw from the study at any point without penalty.

This trial aims to explore effective, non-pharmacological strategies for the management of primary dysmenorrhea and promote physiotherapy-based pain relief methods that can enhance the overall health and well-being of affected women.